[1]徐林飞.尿路感染耐碳青霉烯类肺炎克雷伯菌的临床特点及危险因素分析[J].医学信息,2022,35(21):46-49.[doi:10.3969/j.issn.1006-1959.2022.21.009]
　XU Lin-fei.Analysis of Clinical Characteristics and Risk Factors of Carbapenem-resistant Klebsiella Pneumoniae in Urinary Tract Infection[J].Journal of Medical Information,2022,35(21):46-49.[doi:10.3969/j.issn.1006-1959.2022.21.009]
点击复制

尿路感染耐碳青霉烯类肺炎克雷伯菌的临床特点及危险因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
46-49
栏目:
论著
出版日期:
2022-11-01

文章信息/Info

Title:
Analysis of Clinical Characteristics and Risk Factors of Carbapenem-resistant Klebsiella Pneumoniae in Urinary Tract Infection
文章编号:
1006-1959（2022）21-0046-04
作者:
徐林飞
（台州市立医院泌尿外科，浙江 台州 318000）
Author(s):
XU Lin-fei
(Department of Urology Surgery,Taizhou Municipal Hospital,Taizhou 318000,Zhejiang,China)
关键词:
路感染; 耐碳青霉烯类肺炎克雷伯菌; 药物敏感试验
Keywords:
Urinary tract infection; Carbapenem-resistant Klebsiella pneumoniae; Drug sensitivity test
分类号:
R446.5
DOI:
10.3969/j.issn.1006-1959.2022.21.009
文献标志码:
A
摘要:
目的 对我院尿路感染耐碳青霉烯类肺炎克雷伯菌（CRKP）的临床特点、耐药性及危险因素进行分析，为临床防控提供依据。方法 选择2018年6月-2019年6月我院尿液培养分离出的98株肺炎克雷伯菌（Kpn），收集标本对应的患者临床资料，进行Kpn鉴定与培养、药物敏感试验，按药敏结果分为碳青霉烯耐药组（CRKP）和敏感组（CSKP），分析其临床特点及危险因素。结果 98株Kpn中有40株是CRKP（40.82%）；年龄≥65岁（87.50%）、糖尿病（37.50%）、经尿道操作史（67.50%）及抗生素暴露史患者（95.00%）比例均超过30.00%；尿路感染的CRKP对氨苄西林、头孢曲松、哌拉西林舒巴坦钠的耐药率均达到100.00%，对替加环素（10.00%）、多粘菌素（15.00%）的耐药率较低，低于对碳青霉烯类敏感的CSKP（P＜0.05）；CRKP组患者与CSKP组患者的细菌清除率比较，差异有统计学意义（P＜0.05），两组死亡率比较，差异无统计学意义（P＞0.05）。结论 尿路感染CRKP对抗生素普遍耐药，但对替加环素、多粘菌素仍敏感，建议联合用药。另外，对于年龄大、基础疾病多的患者应减少经尿道操作、大量广谱抗生素的暴露，同时按照药敏试验结果选用敏感抗菌药物降低尿路感染CRKP的发生。
Abstract:
Objective To analyze the clinical characteristics, drug resistance and risk factors of carbapenem-resistant Klebsiella pneumoniae (CRKP) in urinary tract infection in our hospital, and to provide evidence for clinical prevention and control.Methods A total of 98 strains of Klebsiella pneumoniae (Kpn) isolated from urine culture in our hospital from June 2018 to June 2019 were selected. The clinical data of the patients corresponding to the specimens were collected for Kpn identification and culture and drug sensitivity test. According to the results of drug sensitivity, they were divided into carbapenem-resistant group (CRKP) and sensitive group (CSKP), and their clinical characteristics and risk factors were analyzed.Results Totally 40 of 98 strains of Kpn were CRKP (40.82%); the proportion of patients with age≥65 years (87.50%), diabetes (37.50%), history of transurethral operation (67.50%) and history of antibiotic exposure (95.00%) was more than 30.00%. The resistance rates of CRKP to ampicillin, ceftriaxone and piperacillin sulbactam sodium in urinary tract infection were 100.00%, and the resistance rates to tigecycline (10.00%) and polymyxin (15.00%) were lower than those of carbapenem-sensitive CSKP (P<0.05). There was significant difference in bacterial clearance rate between CRKP group and CSKP group (P<0.05). There was no significant difference in mortality between the two groups (P>0.05).Conclusion CRKP in urinary tract infection is generally resistant to antibiotics, but it is still sensitive to tigecycline and polymyxin. It is recommended to combine drugs. In addition, for patients with older age and more underlying diseases, transurethral operation and exposure to a large number of broad-spectrum antibiotics should be reduced, and sensitive antibiotics should be selected according to the results of drug sensitivity test to reduce the occurrence of CRKP in urinary tract infection.

参考文献/References:

[1]Artero-López J,Gutiérrez-Soto B,Expósito-Ruiz M,et al.Etiology of urinary tract infections in our health area and susceptibility profile of the most common uropathogens[J].Archivos Espaｎoles de Urología,2021,74(2):197-207.[2]Karimi K,Zarei O,Sedighi P,et al.Investigation of Antibiotic Resistance and Biofilm Formation in Clinical Isolates of Klebsiella pneumoniae[J].Int J Microbiol,2021,2021:5573388.[3]翁丽贞,朱立岳,陈梦琳,等.不同年龄段老年患者医院获得性尿路感染病原菌分布及耐药性分析[J].检验医学,2016,7(31):576-580.[4]Dai G,Xu Y,Kong H,et al.Klebsiella pneumoniaeRisk factors for carbapenem-resistant infection and associated clinical outcomes[J].Am J Transl Res,2021,13:7276-7281.[5]Ortega M,Marco F,Sorlano A,et al.Epidemiologyandprognostic determinants of bacteraenic catheter-acquired urinaytractinfection in a single institution from 1991 to 2010[J].J Infect,2013,67(4):282-287.[6]Anton Paduraru DT,Miftode EG,Iliescu ML,et al.Knowledge of adolescent girls regarding sexually transmitted diseases a study in a rural area from North Eastern Romania[J].Rev Cercet Interv Soc,2020,69:143-155.[7]王凤,赖开生,安静娜,等.2013-2017年某三甲医院产KPC肺炎克雷伯菌流行特征研究[J].中华医院感染学杂志,2017,27(24):5521-5524,5529.[8]Cui H.Distribution and drug resistance of pathogens causing urinary tract infection in patients with urinary calculi[J].Am J Transl Res,2021,13:10554-10561.[9]Karampatakis T,Tsergouli K,Iosifidis E,et al.Impactof active surveillance and infection control measures on carbapenemresistant Gram-negative bacterial colonization and infections inintensive care[J].J Hosp Infect,2018,99(4):396-404.[10]Vardakas KZ,Matthaiou DK,Falagas ME,et al.Characteristics, risk factorsand outcomes of carbapenem-resistant Klebsiella pneumoniae infections in theintensive care unit[J].J Infect,2015,70(6):592-599.[11]Koksal E,Tulek N,Sonmezer MC,et al.Investigation of risk factors for community acquired urinary tract infections caused by extended spectrum beta lactamase Escherichia coli and Klebsiel species[J].Investig Clin Urol,2019,60:46-53.[12]Tofas P,Skiada A,Angelopoulou M,et al.Carbapenemase producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases[J].Int J Antimicrob Agents,2016,47:335-339.[13]Wang Z,Qin RR,Huang L,et al.Risk factors forcarbapenem-resistant Klebsiella pneumoniaeinfectionandmortality of Klebsiella pneumoniaeinfection[J].Chin Med J,2018,131(1):56-62.[14]Yan JR,Pu SL,Jia XJ,et al. Multidrug resistancemechanisms of carbapenem-resistant Klebsiella pneumoniastrains isolated in chongqing, China[J].Ann Lab Med,2017,37(5):398-407.[15]Gheitani L,Fazeli H,Moghim S,et al.FrequencyDetermination of Carbapenem-Resistant Klebsiella Pneumoniae（CRKP） Isolated from hospitals in Isfahan of Iran and Evaluationof Synergistic Effect of Colistin and Meropenem on them[J].CellMol Biol(Noisy-le-grand),2018,64(1):70-74.[16]Zhang Y,Wang Q,Yin Y,et al.Epidemiology of carbapenem-resistant enterobacteriaceae infections: report from the China CRE network[J].Antimicrob Agents Chemother,2018,62:e01882-e01917[17]Iredell J,Brown J,Tagg K.Antibiotic resistance inEnterobacteriaceae：mechanisms and clinical implications[J].BMJ,2016,352:h6420.[18]Shamsrizi P,Gladstone BP,Carrara E,et al.Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria producing extended spectrum beta lacta mases: A systematic review and meta analysis[J].BMJ Open,2020,10:e030266.[19]Ata A,Hunea IM,Dorneanu O,et al.Biochemical changes and risk factors in the prognosis of antibiotics susceptibility in urinary tract infections[J].Rev Chim,2019,70:1822-1825.[20]Kofteridis DP,Valachis A,Dimopoulou D,et al.Risk factors forcarbapenem-resistant Klebsiella pneumoniae infection/colonization:acase-case-control study[J].J Infect Chemother,2014,20(5):293-297.

相似文献/References:

[1]吴方强,许夕海.2014~2018年我院耐碳青霉烯类肺炎克雷伯菌分布特点及感染患者的临床特点[J].医学信息,2019,32(24):28.[doi:10.3969/j.issn.1006-1959.2019.24.010]
　WU Fang-qiang,XU Xi-hai.Distribution Characteristics of Carbapenem-resistant Klebsiella Pneumoniae in our Hospital from 2014 to 2018 and Clinical Characteristics of Infected Patients[J].Journal of Medical Information,2019,32(21):28.[doi:10.3969/j.issn.1006-1959.2019.24.010]

更新日期/Last Update: 1900-01-01